Genetic variation of Golgi membrane protein 1 is associated with COVID-19 disease - 13/10/22
Doi : 10.1016/j.jinf.2022.07.013
Jiantao Fu a, b, Yuxiao Luo a, c, Xin Fang c, Jianmin Lu c, Jin Yang a, b, ⁎ 
a Department of Translational Medicine Center, The Affiliated Hospital of Hangzhou Normal University, Hangzhou 310015, Zhejiang, PR China
b Institute of Hepatology and Metabolic Diseases, Hangzhou Normal University, Hangzhou 310015, Zhejiang, PR China
c Department of orthopedics, The Affiliated Hospital of Hangzhou Normal University, Hangzhou 310015, Zhejiang, PR China
⁎Corresponding author.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Highlights |
• | There is an causality between GOLM1 and COVID-19. |
• | GOLM1 levels may be linked to high glucose levels during COVID-19 infection. |
• | GOLM1 might be a novel biomarker for COVID-19. |
Plan
© 2022
Publié par Elsevier Masson SAS.
Vol 85 - N° 5
P. e164-e166 - novembre 2022 Retour au numéro
Article précédent
- Resistance mutations in SARS-CoV-2 omicron variant after tixagevimab-cilgavimab treatment
- Camille Vellas, Nassim Kamar, Jacques Izopet
- Erratum to ‘Maternal BCG primes for enhanced health benefits in the newborn’ [Journal of Infection Volume 84, Issue 3 (2022) 321-328]
- Frederik Schaltz-Buchholzer, Christian Bjerregård Øland, Mike Berendsen, Morten Bjerregaard-Andersen, Elise Brenno Stjernholm, Christian N Golding, Ivan Monteiro, Peter Aaby, Christine Stabell Benn
Bienvenue sur EM-consulte, la référence des professionnels de santé.